Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,450 shares at $35.75 ($195K) on 2025-05-07, disclosed to the SEC on 2025-05-09.
Scheduled sale ($195k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.75 | 2,725 | $97K | 50.0% |
| 2 | $35.75 | 2,725 | $97K | 50.0% |
| Total | $35.75 avg | 5,450 | $195K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |